| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 05/29/2001 | US6239151 Compounds as inhibitor of tumor necrosis factor alpha release |
| 05/29/2001 | CA2325783A1 Ultraviolet-protecting cosmetic compounds containing amino- amidine derivatives and uses |
| 05/25/2001 | WO2001036405A1 Method for production of benzofuranone oximes |
| 05/25/2001 | WO2001036403A1 Urea derivatives as anti-inflammatory agents |
| 05/25/2001 | WO2001036363A1 Process for preparing acylaromatic compounds |
| 05/25/2001 | WO2000039081A3 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/24/2001 | US20010001799 Anticoagulant |
| 05/23/2001 | EP1101755A1 Anthranilic acid derivatives |
| 05/23/2001 | EP1100954A1 Continuous process for preparing optically pure (s)-3,4-dihydroxybutyric acid derivatives |
| 05/23/2001 | EP1100953A1 CONTINUOUS PROCESS FOR PREPARING OPTICALLY PURE ($i(S))-3-HYDROXY-GAMA-BUTYROLACTONE |
| 05/23/2001 | EP1100952A1 Process for preparing optically pure (s)-3,4-dihydroxybutyric acid derivatives |
| 05/23/2001 | EP1100951A1 PROCESS FOR PREPARING OPTICALLY PURE ($i(S))-3-HYDROXY-GAMA-BUTYROLACTONE |
| 05/23/2001 | EP1100948A1 Process for preparing alpha-(1,4) linked oligosaccharide |
| 05/23/2001 | EP1100795A1 Disubstituted bicyclic heterocycles having, in particular, a thrombin inhibitive effect |
| 05/23/2001 | EP1100792A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 05/23/2001 | EP1100775A2 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same |
| 05/23/2001 | EP1100763A1 Diketoacid-derivatives as inhibitors of polymerases |
| 05/23/2001 | EP1100483A2 Glucocorticoid-selective anti-inflammatory agents |
| 05/23/2001 | CN1296488A Bicycle hydroxamic acid derivatives |
| 05/23/2001 | CN1296480A Process for preparation of esters or lactones |
| 05/23/2001 | CN1296006A Process for preparing alkali metal salt of L-ascorbic acid |
| 05/23/2001 | CN1295999A Process for preparation of monochlorobenzoyl oxide by liquid phase air oxidation |
| 05/22/2001 | US6235956 Acetalization of ketones with tetrahydrofuran alcohol |
| 05/22/2001 | US6235930 Multistage reaction of sugars |
| 05/22/2001 | US6235912 Sphingosine analogues |
| 05/22/2001 | US6235906 If oxidation of codeine or a salt thereof, for example the phosphate salt, is carried out at acidic ph, a high yield of codeinone is obtained |
| 05/22/2001 | US6235899 Method for preparing alkyloxy furanone derivatives, compounds obtained by said method and use of said compounds |
| 05/22/2001 | US6235791 Using cis n-cyclohexyl-n-ethyl(3-(3-chloro-cyclohexylphenyl)allyl)amine |
| 05/22/2001 | US6235787 Antiinflammatory agents; rheumatic diseases; bone disorders; skin disorders; multiple sclerosis |
| 05/22/2001 | US6235778 Anticoagulants |
| 05/22/2001 | US6235753 Tumor necrosis factor; autoimmune diseases; antiallergens |
| 05/22/2001 | US6235736 3-anilino-2-cycloalkenone derivatives |
| 05/22/2001 | US6235680 N-acylsulfonamides, novel mixtures of herbicides and antidotes, and their use |
| 05/17/2001 | WO2001034594A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
| 05/17/2001 | WO2001034580A1 Heterocycle substituted diphenyl leukotriene antagonists |
| 05/17/2001 | WO2001034135A2 Oncolytic combinations for the treatment of cancer |
| 05/17/2001 | WO2001033966A2 Active ingredient combination having insecticidal and acaricidal characteristics |
| 05/17/2001 | WO2001014358A3 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 05/17/2001 | WO2001002593A3 Control of gene expression in eukaryotic cells |
| 05/17/2001 | DE19954936A1 Verfahren zur Herstellung von Benzofuranonoximen A process for preparing Benzofuranonoximen |
| 05/17/2001 | DE19954511A1 Verfahren zur Herstellung von Alkalisalzen der L-Ascorbinsäure A process for preparing alkali metal salts of L-ascorbic acid |
| 05/17/2001 | CA2391230A1 Heterocycle substituted diphenyl leukotriene antagonists |
| 05/17/2001 | CA2390789A1 Oncolytic combinations for the treatment of cancer |
| 05/17/2001 | CA2390231A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
| 05/16/2001 | EP1099697A1 Process for the preparation of alkali salts of L-ascorbic acid |
| 05/16/2001 | EP1099440A1 Therapeutic agents |
| 05/16/2001 | EP1098874A1 Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments |
| 05/16/2001 | EP1098864A1 Method for hydrogenating unsaturated heterocyclic compounds |
| 05/16/2001 | EP1098662A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
| 05/16/2001 | EP0798288B1 Triciclic compounds |
| 05/16/2001 | EP0695300B1 Novel 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents |
| 05/16/2001 | CN1295567A Polyethoxylated ascorbic acid derivatives as a novel antioxidant and process for preparing thereof |
| 05/16/2001 | CN1295548A Novel tricyclic compound |
| 05/16/2001 | CN1295471A Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
| 05/16/2001 | CN1295065A Phenyl heterocyclic compound used as epoxy enzyme -2 inhibitor |
| 05/16/2001 | CN1295064A Novel tricyclic compound and medicine composition containing the same |
| 05/15/2001 | US6232475 Reacting a substituted bromobenzene with n-vinylimide; catalytic hydrogenation |
| 05/15/2001 | US6232474 Process for the preparation of α-methylenelactones and α-substituted hydrocarbylidene lactones |
| 05/15/2001 | US6232467 Biosynthesis of an amine with ketone and boron compound; compoundlibraries |
| 05/15/2001 | US6232343 A 4,8-inter-m-phenylene prostaglandin 2 derivative for decreasing ocular tension, which has therapeutic and prevention effects against ophthalmic diseases such as glaucoma, hypertonia oculi or cataract |
| 05/15/2001 | US6232342 Protease inhibitors |
| 05/15/2001 | US6232322 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 05/15/2001 | US6232315 Method for treating inflammatory diseases by administering a thrombin inhibitor |
| 05/15/2001 | US6232314 Arylalkylpiperazine compounds as antioxidants |
| 05/10/2001 | WO2001032654A2 Novel heterocyclic compounds and their use as medicines |
| 05/10/2001 | WO2001032643A1 Method for the preparation of 5-carboxyphthalide |
| 05/10/2001 | WO2001032642A1 Method for the preparation of 5-carboxyphthalide |
| 05/10/2001 | WO2001032604A1 Activators of soluble guanylate cyclase |
| 05/10/2001 | WO2001032602A1 Diaryl-enynes |
| 05/10/2001 | US20010000889 Processes for electrically activated transformation of chemical and material compositions |
| 05/10/2001 | DE19953775A1 Wirkstoffkombinationen mit insektiziden und akariziden Eigenschaften Drug combinations with insecticidal and acaricidal properties |
| 05/10/2001 | CA2389773A1 Activators of soluble guanylate cyclase |
| 05/10/2001 | CA2387660A1 Diaryl-enynes as glycine transport inhibitors |
| 05/09/2001 | EP1097719A1 NEP inhibitors for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097718A1 NPY antagonists for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097707A1 Treatment of female sexual dysfunction |
| 05/09/2001 | EP1097706A1 Phosphodiesterase inhibitors for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097382A2 Imidazoline receptor binding compounds |
| 05/09/2001 | EP1097158A2 Ligands for metals and metal-catalyzed processes |
| 05/09/2001 | EP1097128A1 Imidamide derivatives |
| 05/09/2001 | EP1097117A2 Aryl vinyl ether derivatives and their use as herbicides |
| 05/09/2001 | EP0813519B1 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/09/2001 | CN1294571A Process for prepn. of butanediol, butyrolactone and tetrahydrofuran |
| 05/09/2001 | CN1065533C Process for making phenyl heteroxycles useful as cox-2 inhibitors |
| 05/08/2001 | US6229026 Reacting an isobenzofuran derivative with grignard reagents 4-halogen-fluorophenyl and 3-halogen-n,n-dimethylpropylamine; causing ring-closure of the product and conversion to 5-cyano derivative |
| 05/08/2001 | US6228942 Dehydration to esterify or amidate surface of oxidized or aminated carbon powder or fiber suspended in solution containing a monomer or polymer having amine, hydroxy, and/or viny ether groups |
| 05/08/2001 | US6228848 3-(1-propen-3-oxo)-5,6-dihydronaphthalene derivatives; side effect reduction |
| 05/08/2001 | CA2324484A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323464A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323191A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323183A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2167040C New alkylated (hetero)cyclic compounds; process for preparing the same and pharmaceutical compositions containing them |
| 05/08/2001 | CA2018692C Method of preparation of ascorbic acid |
| 05/03/2001 | WO2001030795A1 Hygromycin derivatives |
| 05/03/2001 | WO2001030793A1 Hygromycin a prodrugs |
| 05/03/2001 | WO2001030739A1 Process for the production of adamantyl (meth)acrylates |
| 05/03/2001 | WO2001030736A2 Aromatic di-keto derivatives as glucose-6-phosphate translocase inhibitors |
| 05/03/2001 | WO2001030149A1 Novel succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 05/03/2001 | WO2001030148A1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 05/03/2001 | WO2001002383A3 Process for the synthesis of citalopram |